欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

全球心脏瓣膜市场报告(2016-2020年)

Global Heart Valves Market 2016-2020

加工时间:2016-08-09 信息来源:EMIS 索取原文[66 页]
关键词:心脏瓣膜;替换;缺陷;心脏瓣膜假体;心血管医疗器械;生物;组织;机械;移植;同种移植
摘 要:Heart valves are prosthetic cardiovascular medical devices used to replace a defective heart valve. They can be biological, tissue or mechanical. Manufacturers develop mechanical heart valves from synthetic materials such as pyrolytic carbon, titanium alloy, and cobalt-based alloys and tissue heart valves from bovine, porcine, and human tissues. They also develop transcatheter heart valves with a combination of tissue and synthetic materials. Devices developed using human tissues are known as allografts or homografts. Medical personnel implant transcatheter heart valves through the transfemoral approach (via the femoral artery) and transapical approach (via a small chest incision). Medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.
目 录:

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Cost analysis

Cost analysis of valve replacement procedures

PART 07: Market segmentation by product

Global mechanical heart valves market

Global tissue heart valves market

Global transcatheter heart valves market

PART 08: Geographical segmentation

Heart valves market in Americas

Heart valves market in EMEA

Heart valves market in APAC

PART 09: Market drivers

Incidence of heart valve diseases

Implementation of minimally invasive procedures

Use of transcatheter valve replacement technology

Rise in older population

PART 10: Impact of drivers

PART 11: Market challenges

Risk of potential complications

Lack of skilled personnel

Expensive heart valve replacement procedures

Stringent regulatory framework

PART 12: Impact of drivers and challenges

PART 13: Market trends

Focus on US

Increase in M&A

Use of stentless tissue valves

Development of novel heart valves

PART 14: Vendor landscape

Competitive scenario

Market share analysis 2015

Key vendors

Other prominent vendors

PART 15: Appendix

List of abbreviations

PART 16: Explore Technavio 

© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服